We are excited to announce our investment in IDRx, which is aiming to transform cancer care through intelligently designed combination therapies. Read more from General Partner @JorgeCondeBio https://t.co/tHTSgovSTE
— a16z (@a16z) Aug 2, 2022
from Twitter https://twitter.com/a16z
August 02, 2022 at 09:00AM
via IFTTT
No comments:
Post a Comment